Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.

Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.

Herpesviruses have two distinct life cycle stages, latency and lytic replication. Epstein-Barr virus (EBV), a gamma-herpesvirus, establishes latency in vivo and in cultured cells. Cell lines harboring latent EBV can be induced into the lytic cycle by treatment with chemical inducing agents. In the B...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Kelly L Gorres, David M Reineke, George Miller
Natura:	Articolo
Lingua:	English
Pubblicazione:	Public Library of Science (PLoS) 2024-01-01
Serie:	PLoS ONE
Accesso online:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299198&type=printable

Documenti analoghi

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
di: Kelly L. Gorres, et al.
Pubblicazione: (2016-05-01)

Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
di: Abbie G. Anderson, et al.
Pubblicazione: (2019-05-01)

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
di: Rebecca L. Hutcheson, et al.
Pubblicazione: (2021-01-01)

Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
di: Chris Traylen, et al.
Pubblicazione: (2015-10-01)

Zebularine reactivates silenced <it>E-cadherin </it>but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
di: Nadal David, et al.
Pubblicazione: (2007-01-01)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
di: Takayuki Murata, et al.
Pubblicazione: (2021-11-01)

From virus to cancer: Epstein–Barr virus miRNA connection in Burkitt's lymphoma
di: Shahram Jalilian, et al.
Pubblicazione: (2024-10-01)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
di: Mohsen eNavari, et al.
Pubblicazione: (2014-12-01)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
di: Mohsen eNavari, et al.
Pubblicazione: (2015-06-01)

Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
di: Mutaz Jamal Al-Khreisat, et al.
Pubblicazione: (2023-06-01)

Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
di: Praphatson Malat, et al.
Pubblicazione: (2021-12-01)

Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda
di: Carpenter, L, et al.
Pubblicazione: (2008)

Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
di: Carpenter, L, et al.
Pubblicazione: (2008)

Epstein-Barr virus infection of infants: implications of early age of infection on viral control and risk for Burkitt lymphoma
di: Rosemary Rochford
Pubblicazione: (2016-01-01)

Primary Burkitt′s lymphoma of the breast without Epstein-Barr virus infection: A case report and literature review
di: Jianguo Wei, et al.
Pubblicazione: (2015-01-01)

Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.
di: Carolina Minnicelli, et al.
Pubblicazione: (2012-01-01)

Understanding the mechanism of antiretroviral nucleoside analogs as inhibitors of Epstein-Barr virus lytic DNA replication
di: Drosu, Natalia C.
Pubblicazione: (2020)

Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression.
di: Elliott D SoRelle, et al.
Pubblicazione: (2024-10-01)

Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation
di: Yuchen Zhang, et al.
Pubblicazione: (2020-10-01)

Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus
di: Aygen Yilmaz, et al.
Pubblicazione: (2007-10-01)

Epstein-Barr virus independent dysregulation of UBP43 expression alters interferon-stimulated gene expression in Burkitt lymphoma.
di: Ingrid K Ruf, et al.
Pubblicazione: (2009-06-01)

Profiling genome-wide recombination in Epstein Barr virus reveals type-specific patterns and associations with endemic-Burkitt lymphoma
di: Eddy O. Agwati, et al.
Pubblicazione: (2022-12-01)

Study of Epstein-Barr virus expression in Burkitt′s lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran
di: Parviz Deyhimi, et al.
Pubblicazione: (2014-01-01)

Epstein-Barr Virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma
di: Seuánez Héctor N, et al.
Pubblicazione: (2006-08-01)

Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells.
di: Xiaofan Li, et al.
Pubblicazione: (2017-03-01)

Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
di: Niggli Felix K, et al.
Pubblicazione: (2006-06-01)

Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis
di: Quincy Rosemarie, et al.
Pubblicazione: (2020-11-01)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.
di: Ahmed Ali, et al.
Pubblicazione: (2022-09-01)

Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
di: Gibbons, D, et al.
Pubblicazione: (1994)

Epstein-Barr virus and Burkitt’s lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer
di: Dana N. Muhealdeen, et al.
Pubblicazione: (2022-07-01)

The epstein-Barr virus and the pathogenesis of lymphoma
di: Vockerodt, M., et al.
Pubblicazione: (2015)

Immune Modulation by Epstein–Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis
di: Nevena Todorović, et al.
Pubblicazione: (2024-10-01)

Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
di: Jaeyeun Lee, et al.
Pubblicazione: (2021-04-01)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
di: Atsuko Sugimoto
Pubblicazione: (2022-04-01)

ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
di: Xianming Yu, et al.
Pubblicazione: (2007-12-01)

Calcium mobilization is responsible for Thapsigargin induced Epstein Barr virus lytic reactivation in in vitro immortalized lymphoblastoid cell lines
di: Aki Hoji, et al.
Pubblicazione: (2018-11-01)

Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
di: Yen-Ju Chen, et al.
Pubblicazione: (2011-03-01)

Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.
di: Julie Gonin, et al.
Pubblicazione: (2011-01-01)

Epstein-Barr Virus miR-BARTs 7 and 9 modulate viral cycle, cell proliferation, and proteomic profiles in Burkitt lymphoma
di: Brunno Felipe Ramos Caetano, et al.
Pubblicazione: (2024-06-01)

Assessment of the Combined Effect of Epstein–Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach
di: Ruth Aguilar, et al.
Pubblicazione: (2017-10-01)